Contract facts
NONEEO 14398 (P00100) NUCLEAR MEDICINE IMAGING RADIO-THERAPEUTIC ISOTOPES - REDUCTION IN SCOPE is a federal NONE award for 256-Network Contract Office 16 (36C256) held by Jubilant Draximage Radiopharmacies, Inc. Estimated value —. Related solicitation 36C25624Q0136.
EO 14398 (P00100) NUCLEAR MEDICINE IMAGING RADIO-THERAPEUTIC ISOTOPES - REDUCTION IN SCOPE
Incumbent footprint
Public recordJubilant Draximage Radiopharmacies, Inc — $14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25624D0032?
36C25624D0032 (P00100 EO 14398 nuclear medicine) is a 256-Network Contract Office 16 (36C256) award with an estimated value of —, currently held by Jubilant Draximage Radiopharmacies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C256-24-D-0032?
36C256-24-D-0032 is the dashed form of PIID 36C25624D0032 (P00100 EO 14398 nuclear medicine), held by Jubilant Draximage Radiopharmacies, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25624D0032?
256-Network Contract Office 16 (36C256) awarded 36C25624D0032 to Jubilant Draximage Radiopharmacies, Inc.
Who is the incumbent on 36C25624D0032?
Jubilant Draximage Radiopharmacies, Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint.
When does Jubilant Draximage Radiopharmacies, Inc’s 36C25624D0032 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
